These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 24337069

  • 21. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z.
    Int J Mol Sci; 2017 Jun 16; 18(6):. PubMed ID: 28621736
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q, Wang C, Lu Z, Guo L, Ge Q.
    Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599
    [Abstract] [Full Text] [Related]

  • 24. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.
    Liao WT, Li TT, Wang ZG, Wang SY, He MR, Ye YP, Qi L, Cui YM, Wu P, Jiao HL, Zhang C, Xie YJ, Wang JX, Ding YQ.
    Clin Cancer Res; 2013 Sep 01; 19(17):4662-72. PubMed ID: 23846336
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.
    Hepatology; 2008 Jun 01; 47(6):1955-63. PubMed ID: 18433021
    [Abstract] [Full Text] [Related]

  • 27. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
    Dip N, Reis ST, Timoszczuk LS, Viana NI, Piantino CB, Morais DR, Moura CM, Abe DK, Silva IA, Srougi M, Dall'Oglio MF, Leite KR.
    J Urol; 2012 Nov 01; 188(5):1951-6. PubMed ID: 22999546
    [Abstract] [Full Text] [Related]

  • 28. High-throughput approaches for microRNA expression analysis.
    Dedeoğlu BG.
    Methods Mol Biol; 2014 Nov 01; 1107():91-103. PubMed ID: 24272433
    [Abstract] [Full Text] [Related]

  • 29. Identification and characterization of novel microRNA candidates from deep sequencing.
    Wu Q, Wang C, Guo L, Ge Q, Lu Z.
    Clin Chim Acta; 2013 Jan 16; 415():239-44. PubMed ID: 23153516
    [Abstract] [Full Text] [Related]

  • 30. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.
    J Hum Genet; 2012 Nov 26; 57(11):691-9. PubMed ID: 22854542
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.
    RNA; 2008 Nov 26; 14(11):2348-60. PubMed ID: 18812439
    [Abstract] [Full Text] [Related]

  • 32. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC.
    Oncogene; 2012 May 10; 31(19):2401-11. PubMed ID: 21927029
    [Abstract] [Full Text] [Related]

  • 33. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.
    Int J Oncol; 2011 Aug 10; 39(2):409-15. PubMed ID: 21567082
    [Abstract] [Full Text] [Related]

  • 34. The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
    Porkka KP, Ogg EL, Saramäki OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi OP, Jenster G, Visakorpi T.
    Genes Chromosomes Cancer; 2011 Jul 10; 50(7):499-509. PubMed ID: 21472816
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.
    Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859
    [Abstract] [Full Text] [Related]

  • 36. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma.
    de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RM.
    Mol Cell Probes; 2015 Dec 01; 29(6):420-426. PubMed ID: 26297962
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
    Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Chen J, Li Z, Tang A, Li X, Ye J, Guan Z, Gui Y, Cai Z.
    PLoS One; 2011 Mar 28; 6(3):e18286. PubMed ID: 21464941
    [Abstract] [Full Text] [Related]

  • 38. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
    Rachagani S, Macha MA, Menning MS, Dey P, Pai P, Smith LM, Mo YY, Batra SK.
    Oncotarget; 2015 Nov 24; 6(37):40295-309. PubMed ID: 26516699
    [Abstract] [Full Text] [Related]

  • 39. Fluctuating expression of microRNAs in adenovirus infected cells.
    Zhao H, Chen M, Tellgren-Roth C, Pettersson U.
    Virology; 2015 Apr 24; 478():99-111. PubMed ID: 25744056
    [Abstract] [Full Text] [Related]

  • 40. miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis.
    Gu YQ, Gong G, Xu ZL, Wang LY, Fang ML, Zhou H, Xing H, Wang KR, Sun L.
    Int J Mol Med; 2014 May 24; 33(5):1243-9. PubMed ID: 24584717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.